Proteomics and protein arrays Europa

Pharmacogenomics

Volumn 4, Issue 4, 2003, Pages 383-385

  Jain, K K ^a  

^a JAIN PHARMABIOTECH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; NEW DRUG; PROTEIN;

BIOINFORMATICS; BIOTECHNOLOGY; CELL LYSATE; CONFERENCE PAPER; DENMARK; DRUG INDUSTRY; DRUG RESEARCH; DRUG TARGETING; EUROPE; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN NUCLEIC ACID INTERACTION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; PROTEOMICS; SIGNAL TRANSDUCTION; SURFACE PLASMON RESONANCE;

EUROPE; PROTEIN ARRAY ANALYSIS; PROTEOMICS;

EID: 0038783659     PISSN: 14622416     EISSN: None     Source Type: Journal    
DOI: 10.1517/phgs.4.4.383.22756     Document Type: Conference Paper

References (6)

1. Jain KK: Proteomics: Technologies, Markets and Companies. Jain PharmaBiotech Publications, Basel, (2003).
2. Liu MY, Cai S, Espejo A, Bedford MT, Walker CL: 14-3-3 interacts with the tumor suppressor tuberin at Akt phosphorylation site(s). Cancer Res. 62, 6475-6480 (2002).
3. Kingsmore SF, Patel DD: Multiplexed protein profiling on antibody-based microarrays by rolling circle amplification. Curr. Opin. Biotechnol. 14, 74-81 (2003).
4. Yip TT, Lomas L: SELDI ProteinChip array in oncoproteomic research. Technol. Cancer Res. Treat. 1, 273-280 (2002).
5. Smith D, Collins BD, Heil J, Koch TH: Sensitivity and specificity of photoaptamer probes. Mol. Cell Proteomics 2, 11-8 (2003).
6. Orchard S, Hermjakob H, Apweiler R: The Proteomics Standards Initiative. Proteomics 7 (In Press) (2003).